Jesús Rivera-Nieves Selected Research

Jesús Rivera-Nieves Research Topics

Disease

17	Ileitis 01/2020 - 11/2002
15	Inflammation (Inflammations) 06/2021 - 04/2003
8	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 07/2003
8	Crohn Disease (Crohn's Disease) 02/2013 - 11/2002
6	Colitis 01/2022 - 08/2004
4	Multiple Sclerosis 08/2021 - 12/2008
4	Ulcerative Colitis 01/2020 - 11/2013
3	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2021 - 12/2008
3	Disease Progression 11/2006 - 04/2003
2	Hypertrophy 11/2011 - 04/2003
1	Anemia 06/2021
1	Leukopenia 06/2021
1	Infections 06/2021
1	Macular Edema 06/2021
1	COVID-19 06/2021
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Tertiary Lymphoid Structures 01/2013
1	Necrosis 08/2012
1	Weight Loss (Weight Reduction) 05/2012
1	Hyperplasia 11/2011
1	Colonic Neoplasms (Colon Cancer) 02/2010
1	Skin Manifestations 02/2002
1	Abdominal Pain (Pain, Abdominal) 02/2002

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2022 - 11/2002
5	AntibodiesIBA 11/2015 - 07/2003
5	LigandsIBA 11/2015 - 04/2006
5	Chemokine ReceptorsIBA 06/2015 - 11/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011 - 07/2003
4	IntegrinsIBA 01/2022 - 02/2005
4	Cell Adhesion Molecule-1IBA 01/2020 - 02/2005
4	L-SelectinIBA 05/2007 - 08/2004
3	ChemokinesIBA 11/2015 - 02/2010
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 08/2021 - 06/2021
2	Transaminases (Aminotransferases)IBA 06/2021 - 02/2002
2	ozanimodIBA 06/2021 - 11/2015
2	Fingolimod Hydrochloride (FTY720)FDA Link 06/2021 - 11/2013
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 08/2004
2	Sphingosine-1-Phosphate ReceptorsIBA 11/2015 - 11/2013
2	Natalizumab (Tysabri)FDA Link 11/2013 - 12/2008
2	ElementsIBA 05/2011 - 12/2008
2	ImmunosorbentsIBA 12/2008 - 11/2006
2	EnzymesIBA 12/2008 - 11/2006
2	P-SelectinIBA 05/2007 - 04/2006
2	Glycoproteins (Glycoprotein)IBA 05/2007 - 04/2006
1	Immunoglobulin A (IgA)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Retinal DehydrogenaseIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	ponesimodIBA 06/2021
1	etrasimodIBA 06/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2021
1	siponimodIBA 06/2021
1	4-deoxypyridoxineIBA 01/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020
1	Interleukin-12 (IL 12)IBA 01/2020
1	Dextrans (Dextran)FDA Link 01/2020
1	sphingosine 1-phosphate lyase (aldolase)IBA 01/2020
1	imidazoleIBA 01/2020
1	LyasesIBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2019
1	tofacitinibIBA 01/2019
1	etrolizumabIBA 11/2015
1	vedolizumabIBA 11/2015
1	Pharmaceutical PreparationsIBA 11/2013
1	Biomarkers (Surrogate Marker)IBA 02/2013
1	LuciferasesIBA 02/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2013
1	Chemokine CCL21IBA 01/2013
1	flt3 ligand protein (flt3 ligand)IBA 08/2012
1	CX3C Chemokine Receptor 1IBA 08/2012
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 05/2012
1	Netrin-1IBA 05/2012
1	Fibronectins (Fibronectin)IBA 11/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2011
1	Interleukin-1 (Interleukin 1)IBA 10/2011
1	Dextran SulfateIBA 10/2011
1	InterleukinsIBA 10/2011
1	Indicators and Reagents (Reagents)IBA 05/2011
1	Monoclonal AntibodiesIBA 05/2011
1	efalizumab (Raptiva)FDA Link 12/2008
1	Cell Adhesion MoleculesIBA 12/2008
1	Hyaluronic Acid (Hyaluronan)IBA 12/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2008
1	E-SelectinIBA 05/2007
1	integrin beta7IBA 02/2005
1	CollagenIBA 04/2003
1	Interferon-gamma (Interferon, gamma)IBA 04/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2002
1	Ciprofloxacin (Cipro)FDA LinkGeneric 11/2002
1	Metronidazole (Metric)FDA LinkGeneric 11/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 11/2002
1	Oral Administration 01/2020
1	Microbubbles 02/2013